Howard Kim

About the Author Howard Kim


Oppenheimer Believes Urogen Pharma Ltd (URGN) Still Has Room to Grow

Oppenheimer analyst Leland Gershell reiterated a Buy rating on Urogen Pharma Ltd (NASDAQ: URGN) yesterday and set a price target of $75. The …

Credit Suisse Maintains Their Hold Rating on Alliance Data Systems

Credit Suisse analyst Paul Condra maintained a Hold rating on Alliance Data Systems (NYSE: ADS) yesterday and set a price target of $200. …

Credit Suisse Sticks to Its Hold Rating for Eli Lilly & Co

Credit Suisse analyst Vamil Divan maintained a Hold rating on Eli Lilly & Co (NYSE: LLY) yesterday and set a price target of …

Aegis Capital Believes Shutterfly (SFLY) Still Has Room to Grow

Aegis Capital analyst Victor Anthony maintained a Buy rating on Shutterfly (NASDAQ: SFLY) yesterday and set a price target of $105. The company’s …

Aerie Pharma Received its Third Buy in a Row

After Cantor Fitzgerald and H.C.

Cowen & Co. Reaffirms Their Hold Rating on ArcelorMittal

Cowen & Co. analyst Novid Rassouli reiterated a Hold rating on ArcelorMittal (NYSE: MT) today and set a price target of $38.

Chardan Capital Believes Crispr Therapeutics AG (CRSP) Still Has Room to Grow

Chardan Capital analyst Gbola Amusa maintained a Buy rating on Crispr Therapeutics AG (NASDAQ: CRSP) today and set a price target of $72.50.

MEI Pharma Gets a Buy Rating from Oppenheimer

Oppenheimer analyst Leah R. Cann maintained a Buy rating on MEI Pharma (NASDAQ: MEIP) today and set a price target of $4.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts